Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Neocolipor   
Auth. number : EU/2/98/008
INN : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI09 - Immunologicals for suidae
Pharmacological subgroup: QI09A - Pig
Chemical subgroup: QI09AB - Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
Chemical substance: QI09AB02 - Escherichia
(See WHO ATCvet Index)
Indication: Reduction of mortality caused by enterotoxicosis associated with E. coli F5 (K99) adhesin during the first days of life as a supplement to colostrom from the dam.
Marketing Authorisation Holder: Merial
29 avenue Tony Garnier, F-69007 Lyon, France

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/03/1998 Centralised - Authorisation EMEA/V/C/35 (1998)937 of 14/04/1998
21/11/2002 Centralised - Notification EMEA/V/C/35/N (2002)4575 of 20/11/2002
22/05/2003 Centralised - Renewal EMEA/V/C/35/R/2 (2003)1718 of 19/05/2003
23/10/2003 Centralised - Variation EMEA/V/C/35/I/3 (2003)3955 of 17/10/2003
15/10/2004 Centralised - Variation (no change in Commission Decision) EMEA/V/C/35/II/4
18/01/2005 Centralised - Notification EMEA/V/C/35/N/5
Updated with Decision(2005)2697 of 07/07/2005
11/07/2005 Centralised - Variation EMEA/V/C/35/II/6 (2005)2697 of 07/07/2005
13/03/2008 Centralised - Renewal EMEA/V/C/35/R/7 (2008)1060 of 11/03/2008